Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Comparison of cardiometabolic risk biomarkers from a national clinical laboratory with the US adult population.

Wolin E, White J, Pottala JV, Sasinowski M, Dall T, Dayspring TD, McConnell JP, Hoefner DM, Varvel SA, Thiselton DL, Warnick GR, Harris WS.

J Clin Lipidol. 2015 Nov-Dec;9(6):817-823. doi: 10.1016/j.jacl.2015.07.014. Epub 2015 Aug 8.

PMID:
26687703
2.

Hypertriglyceridaemia unresponsive to multiple treatments.

Backes JM, Dayspring TD, Hoefner DM, Moriarty PM.

BMJ Case Rep. 2015 Oct 14;2015. pii: bcr2015210788. doi: 10.1136/bcr-2015-210788.

3.

Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: the Multi-Ethnic Study of Atherosclerosis.

Guan W, Cao J, Steffen BT, Post WS, Stein JH, Tattersall MC, Kaufman JD, McConnell JP, Hoefner DM, Warnick R, Tsai MY.

Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):996-1001. doi: 10.1161/ATVBAHA.114.304785. Epub 2015 Feb 19.

4.

Lipoprotein(a) mass: a massively misunderstood metric.

McConnell JP, Guadagno PA, Dayspring TD, Hoefner DM, Thiselton DL, Warnick GR, Harris WS.

J Clin Lipidol. 2014 Nov-Dec;8(6):550-3. doi: 10.1016/j.jacl.2014.08.003. Epub 2014 Aug 19. Review.

PMID:
25499936
5.

Validation of a lipoprotein(a) particle concentration assay by quantitative lipoprotein immunofixation electrophoresis.

Guadagno PA, Summers Bellin EG, Harris WS, Dayspring TD, Hoefner DM, Thiselton DL, Stanovick B, Warnick GR, McConnell JP.

Clin Chim Acta. 2015 Jan 15;439:219-24. doi: 10.1016/j.cca.2014.10.013. Epub 2014 Oct 16.

6.

New automated assay of small dense low-density lipoprotein cholesterol identifies risk of coronary heart disease: the Multi-ethnic Study of Atherosclerosis.

Tsai MY, Steffen BT, Guan W, McClelland RL, Warnick R, McConnell J, Hoefner DM, Remaley AT.

Arterioscler Thromb Vasc Biol. 2014 Jan;34(1):196-201. doi: 10.1161/ATVBAHA.113.302401. Epub 2013 Nov 14.

7.

In reply.

Cole TG, Contois JH, Csako G, McConnell JP, Remaley AT, Devaraj S, Hoefner DM, Mallory T, Sethi AA, Warnick GR.

Clin Chem. 2013 Aug;59(8):1277-8. No abstract available.

8.

Myocardial tissue remodeling in adolescent obesity.

Shah RV, Abbasi SA, Neilan TG, Hulten E, Coelho-Filho O, Hoppin A, Levitsky L, de Ferranti S, Rhodes ET, Traum A, Goodman E, Feng H, Heydari B, Harris WS, Hoefner DM, McConnell JP, Seethamraju R, Rickers C, Kwong RY, Jerosch-Herold M.

J Am Heart Assoc. 2013 Aug 20;2(4):e000279. doi: 10.1161/JAHA.113.000279.

9.

Association of apolipoprotein B and nuclear magnetic resonance spectroscopy-derived LDL particle number with outcomes in 25 clinical studies: assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices.

AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices, Cole TG, Contois JH, Csako G, McConnell JP, Remaley AT, Devaraj S, Hoefner DM, Mallory T, Sethi AA, Warnick GR.

Clin Chem. 2013 May;59(5):752-70. doi: 10.1373/clinchem.2012.196733. Epub 2013 Feb 5. Erratum in: Clin Chem. 2013 Aug;59(8):1275.

10.

Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices.

Contois JH, McConnell JP, Sethi AA, Csako G, Devaraj S, Hoefner DM, Warnick GR; AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices.

Clin Chem. 2009 Mar;55(3):407-19. doi: 10.1373/clinchem.2008.118356. Epub 2009 Jan 23.

11.

The cholesterol controversy continues.

Hoefner DM.

MLO Med Lab Obs. 2008 Apr;40(4):24, 26, 28 passim. No abstract available.

PMID:
18488541
12.

Lipoprotein-associated phospholipase A2.

McConnell JP, Hoefner DM.

Clin Lab Med. 2006 Sep;26(3):679-97, vii. Review.

PMID:
16938590
13.

New HDL-cholesterol reagent formulation reduces interference from samples with abnormal proteins.

Hoefner DM.

Clin Chim Acta. 2006 Dec;374(1-2):142-4. Epub 2006 May 15. No abstract available.

PMID:
16701600
14.

Serum tumor markers: part II--practical considerations and limitations of testing.

Hoefner DM.

MLO Med Lab Obs. 2006 Feb;38(2):10-1, 14-6; quiz 18-9.

PMID:
16583620
15.

Serum tumor markers. Part I: Clinical utility.

Hoefner DM.

MLO Med Lab Obs. 2005 Dec;37(12):20, 22-4.

PMID:
16435773
16.

The ruthless malady: metabolic syndrome.

Hoefner DM.

MLO Med Lab Obs. 2003 Oct;35(10):12-6, 20, 22-3; quiz 24-5. No abstract available.

PMID:
14571847
17.

Lot-to-lot inconsistency of anticardiolipin reagents.

Hoefner DM, Yeo KT.

Clin Chem. 2002 Sep;48(9):1625-6; author reply 1626. No abstract available.

18.

Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System.

Hoefner DM, Hodel SD, O'Brien JF, Branum EL, Sun D, Meissner I, McConnell JP.

Clin Chem. 2001 Feb;47(2):266-74.

21.

Supplemental Content

Loading ...
Support Center